Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to predict dialysis danger in ICU patients

NCT ID NCT07643597

Knowledge-focused Sponsor: Hospital Las Higueras Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 09, 2026 · Updated 4 times

Summary

This study will observe 128 critically ill patients with acute kidney injury who need dialysis to remove excess fluid. Researchers want to understand why some patients become unstable during fluid removal. They will monitor heart function, blood flow, and other signs before and during treatment to find early warning signals. The goal is to make dialysis safer by tailoring fluid removal to each patient.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors identify which patients are at risk of complications during fluid removal, leading to safer, personalized dialysis in the ICU.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not apply to all ICU patients or lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 128 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult critically ill patients admitted to participating intensive care units with acute kidney injury requiring continuous renal replacement therapy and prescribed net ultrafiltration as part of routine clinical care.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥18 years * Admission to an Intensive Care Unit * Acute kidney injury according to KDIGO criteria * Prescription of continuous renal replacement therapy (CRRT) with net ultrafiltration * Clinical stability considered sufficient to initiate net ultrafiltration according to the treating clinical team Exclusion Criteria: * Chronic kidney replacement therapy prior to ICU admission * Pregnancy * Limitation of therapeutic effort or goals-of-care decisions at admission or during the observation period * Inability to perform hemodynamic or perfusion assessment * Extracorporeal membrane oxygenation (ECMO) * Refusal to participate in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute kidney injury are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute kidney injury Critical Illness Edema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute kidney injury Critical illness Fluid overload Fluid overload in dialysis patients Renal replacement therapy for acute kidney injury in icu

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    10 sites in 7 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Complejo Asistencial Dr. Victor Ríos Ruiz

    NOT_YET_RECRUITING

    Los Ángeles, Chile

  • Hospital Clínico Dra. Eloísa Díaz Insunza de La Florida

    NOT_YET_RECRUITING

    Santiago, Chile

  • Hospital Clínico Regional de Concepción

    NOT_YET_RECRUITING

    Concepción, Chile

  • Hospital Cárdio Pulmonar

    NOT_YET_RECRUITING

    Salvador, Brazil

  • Hospital General Enrique Garces

    NOT_YET_RECRUITING

    Quito, Ecuador

  • Hospital General de Mexico

    RECRUITING

    Mexico City, Mexico

  • Hospital Las Higueras de Talcahuano

    RECRUITING

    Talcahuano, Chile

  • Hospital Nacional Cayetano Heredia

    NOT_YET_RECRUITING

    Lima, Peru

  • Hospital Universitario San José de Popayán

    RECRUITING

    Popayán, Colombia

  • Ospedale San Bortolo

    NOT_YET_RECRUITING

    Vicenza, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.